2003 SEP 25 - (NewsRx.com & NewsRx.net) -- Cerner Corporation (CERN) announced that Cerner Millennium PathNet Blood Bank Donor has received U.S. Food and Drug Administration (FDA) 510(k) premarket notification clearance.
Cerner will immediately make the innovative solution available to clients.
"We are very pleased that PathNet Blood Bank Donor has received FDA clearance and is now available," said J.P. Fingado, vice president for Cerner's laboratory enterprise. "It's a key component within our unified PathNet laboratory suite, empowering healthcare organizations to build their laboratory businesses, streamline lab processes, and increase patient safety." …
No comments:
Post a Comment